Pristyn Care has 6 close competitors: Benchling, Kry (Livi), Molbio Diagnostics.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
Pristyn CareBenchlingKry (Livi)Molbio DiagnosticsNeuralinkAbridgeGurugram-based health-tech company offering minimally invasive medical and surgical interventions through a network of partner hospitals and clinics; Canborsa offers exposure to a price on this private company, never a purchase of its shares.
Pristyn Care competes with 6 companies here: Benchling, Kry (Livi), Molbio Diagnostics, Neuralink, Abridge, Alloy Therapeutics.
Pristyn Care was last valued at $1.4B (post-money, Jul 2025). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
No. Pristyn Care is a private company; its shares do not trade on a public exchange.
The last valuation is $1.4B (post-money, Jul 2025).
Lead investors for each round are in the funding timeline.
The closest healthcare / health-tech (surgical care delivery) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
